Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together than alone, likely due to complementary mechanisms. They also uncovered a new role for the PCK1 protein in fat metabolism.
from Top Health News -- ScienceDaily https://ift.tt/Pa7Oxym
Subscribe to:
Post Comments (Atom)
-
Three treaties between the US and Hong Kong were suspended, the latest move to pressure China. from Yahoo News - Latest News & Headl...
-
At least 22 people were killed and 171 others injured on Sunday when one of Taiwan’s newer, faster trains derailed on a curve along a popula...
-
Prosecutors in Mexico have opened an investigation into former president Enrique Peña Nieto, who is accused of taking bribes in one of Latin...
No comments:
Post a Comment